Clinical Trial Update: Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update showing results for SHR-1918 in hyperlipidemia, detailing efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• SHR-1918

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Hyperlipidemia | Phase 2 | Status: COMPLETED